The Impact of Real-World Analyses in the Utilization of CAR T-Cell Therapy in LBCL

News
Video

Thought leaders discuss patient scenarios and different factors to consider when deciding how to select and utilize bridging therapy in the management of patients with LBCL.

Recent Videos
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Ben Samelson-Jones, MD, PhD, assistant professor pediatric hematology, Perelman School of Medicine, University of Pennsylvania and Associate Director, Clinical In Vivo Gene Therapy, Children’s Hospital of Philadelphia
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Steven W. Pipe, MD, a professor of pediatric hematology/oncology at CS Mott Children’s Hospital
Haydar Frangoul, MD, the medical director of pediatric hematology/oncology at Sarah Cannon Research Institute and Pediatric Transplant and Cellular Therapy Program at TriStar Centennial
Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center
Chun-Yu Chen, PhD, a research scientist at Seattle Children’s Research Institute
Michael Severino on In Vivo Gene Editing With RNA Gene Writers
Chris Wright, MD, PhD, on Annelloviruses, a Potential Alternative to AAV for Gene Therapy
Related Content
CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – January 10, 2025

CGTLive Staff
January 10th 2025
Article

Review top news and interview highlights from the week ending January 10, 2025.

ImmunoLogic

CGTLive® Presents: ImmunoLogic, A Video Podcast With Joseph Fraietta, PhD

Joseph A. Fraietta, PhD;Noah Stansfield;Matt Hoffman
December 18th 2024
Podcast

Hosted by Joseph Fraietta, PhD, ImmunoLogic will be tailored for an audience fluent in the language of medicine and biotechnology, offering data-driven insights while maintaining accessibility.

Around the Helix: Cell and Gene Therapy Company Updates – January 8, 2025

Around the Helix: Cell and Gene Therapy Company Updates – January 8, 2025

Noah Stansfield
January 8th 2025
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Data Roundup: December 2024 Features Updates for Cilta-Cel in Multiple Myeloma, mRNA CAR-T in Myasthenia Gravis, and More

Data Roundup: December 2024 Features Updates for Cilta-Cel in Multiple Myeloma, mRNA CAR-T in Myasthenia Gravis, and More

CGTLive Staff
January 6th 2025
Article

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

FDA Activity Recap: December 2024 Features New Approval, a Clinical Hold, and More

FDA Activity Recap: December 2024 Features New Approval, a Clinical Hold, and More

CGTLive Staff
January 5th 2025
Article

Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – January 3, 2025

CGTLive Staff
January 3rd 2025
Article

Review top news and interview highlights from the weeks ending December 27, 2024, and January 3, 2025.

© 2025 MJH Life Sciences

All rights reserved.